A method to measure clinical practice patterns of breast cancer genomic diagnostics in health systems

Personalized Medicine
Nelson A Atehortua, Amalia M Issa

Abstract

Personalized genomic diagnostics, often in combination with targeted therapeutics, have become an important component of clinical oncologic practice over the last decade. However, there is a dearth of studies examining utilization of specific genomic diagnostics and their influence on clinical practice patterns in health systems. In order to begin to explore and understand the clinical utility of particular genomic diagnostics in current use, we developed an instrument to collect data on utilization and clinical practice patterns in health systems. We focused our efforts on gene-expression profiling (GEP) assays, particularly on a commonly used GEP in breast cancer: Oncotype DX® (Genomic Health, Inc., CA, USA). This article presents a method we have developed for the retrospective collection of data on the utilization of GEP among breast cancer patients of a real-world, real-time health system.

References

Mar 19, 2002·Journal of Manipulative and Physiological Therapeutics·Joanne NyiendoMitchell Haas
Jul 31, 2002·Health Care Management Review·Jean-Louis DenisLouise-Hélène Trottier
Jan 11, 2003·American Journal of Clinical Pathology·Jeffrey S Ross, Geoffrey S Ginsburg
Apr 17, 2003·JAMA : the Journal of the American Medical Association·Donald M Berwick
Mar 30, 2005·Annals of Emergency Medicine·Andrew WorsterKevin Eva
Apr 27, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kelly-Anne PhillipsJohn L Hopper
May 5, 2005·American Journal of Epidemiology·Barbara P Yawn, Peter Wollan
May 4, 2006·Annals of Internal Medicine·Brenda E SirovichElliott S Fisher
Jun 20, 2007·BMC Medical Research Methodology·Soe Soe ThwinRebecca A Silliman
Aug 19, 2007·BMC Genomics·Kim M Clark-LangoneMaureen T Cronin
Oct 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lyndsay HarrisUNKNOWN American Society of Clinical Oncology
Feb 7, 2008·Annals of Internal Medicine·Luigi MarchionniSteven N Goodman
Feb 22, 2008·Journal of Public Health Management and Practice : JPHMP·James W Dearing
Jul 11, 2008·Critical Reviews in Oncology/hematology·Zsofia K Stadler, Steven E Come
Dec 20, 2008·The Journal of Urology·Brian R LaneBryan R G Williams
Jan 7, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·UNKNOWN Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Mar 13, 2009·Medical Care Research and Review : MCRR·Bonnie B DeanRobert J Nordyke
Jun 19, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Danny Rischin
Jan 13, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shelly S LoKathy S Albain
Jul 1, 2010·Clinical Breast Cancer·Jennifer Eng-Wong, Claudine Isaacs
Jul 14, 2010·Surgical Oncology Clinics of North America·Joseph A SparanoParaic A Kenny
Oct 27, 2010·Applied Nursing Research : ANR·Katherine E Gregory, Lucy Radovinsky
Nov 3, 2010·Current Genomics·Rachel E EllsworthDarrell L Ellsworth
Jan 5, 2011·Breast Cancer Research and Treatment·Foluso O AdemuyiwaSunil Badve
Jan 21, 2011·Clinical Pharmacology and Therapeutics·R A WilkeG Savova
Mar 29, 2011·Annals of Surgical Oncology·Benjamin W LambNick Sevdalis
Jun 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Dec 22, 2011·Journal of the National Comprehensive Cancer Network : JNCCN·Phillip G FebboMarian L Birkeland
May 16, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J HassettJane C Weeks

❮ Previous
Next ❯

Citations

Sep 1, 2016·Journal of Oncology Practice·Susan K ParsonsJohn K Erban

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.